• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® DRYSEAL FLEX INTRODUCER SHEATH; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® DRYSEAL FLEX INTRODUCER SHEATH; INTRODUCER, CATHETER Back to Search Results
Model Number DSF2233
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problem Perforation of Vessels (2135)
Event Date 10/27/2021
Event Type  Injury  
Event Description
On (b)(6) 2021, the patient underwent endovascular treatment of thoracic aneurysm enlargement using a gore® tag® conformable thoracic stent graft with active control system.During the procedure, a 22fr gore® dryseal flex introducer sheath was inserted from the left femoral artery.According to the report, resistance was felt while advancing the sheath.The reason for the resistance felt while advancing the sheath was unknown.The diameter of the access vessel from the left femoral artery to the external iliac artery measured a reported 6.1mm to 8.2mm.After all gore® tag® devices were implanted, the left external iliac artery was reportedly ruptured upon removal of the sheath.The area of sheath insertion was surgically repaired.The patient tolerated the procedure.
 
Manufacturer Narrative
A review of the manufacturing records for the device verified that the lot met all pre-release specifications.The device was discarded at the facility and, therefore, was not available for direct analysis by gore.It should be noted that, per the gore® dryseal flex introducer sheath instructions for use (ifu), the nominal body outer diameter of a 22fr gore® dryseal flex introducer sheath is 8.2mm.The diameter of the access vessel from the left femoral artery to the external iliac artery in this case measured a reported 6.1mm to 8.2mm.The ifu states ¿adequate vessel access is required to introduce the sheath into the vasculature.Careful evaluation of vessel size, anatomy, tortuosity, and disease state (including calcification, plaque, and thrombus) is required to ensure successful sheath introduction and subsequent withdrawal.If vessel is not adequate for access, major bleeding, vessel damage, or serious injury to the patient, including death, may result.¿ additionally, per ifu, if vessel size is smaller than the nominal body outer diameter, major bleeding, vessel damage, or serious injury to the patient, including death, may result.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® DRYSEAL FLEX INTRODUCER SHEATH
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL PHOENIX 1 B/P
32360 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
damon jackson
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key12853181
MDR Text Key284469305
Report Number3007284313-2021-01672
Device Sequence Number1
Product Code DYB
UDI-Device Identifier00733132630073
UDI-Public00733132630073
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K160254
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 11/22/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/22/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberDSF2233
Device Catalogue NumberDSF2233
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/27/2021
Date Device Manufactured06/17/2021
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age75 YR
Patient SexFemale
-
-